Format

Send to

Choose Destination
See comment in PubMed Commons below
Hematol Oncol Clin North Am. 1996 Jun;10(3):691-701.

Quality of life in early prostate cancer. Do we know enough to treat?

Author information

  • 1Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Abstract

Informed consent is especially important for patients with early (nonmetastatic) prostate cancer. Because it occurs in older men and usually grows slowly, most newly diagnosed patients are likely to live many years and most likely will die without symptoms of metastatic cancer. The complications of treatment, however, may begin within months and be permanent. Recent studies using modern survey techniques are beginning to provide accurate information on treatment complications. A careful, thorough discussion between doctor and patient is necessary to identify the best available therapy for each patient.

PMID:
8773505
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk